Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) Tax Rate (2022 - 2025)

Historic Tax Rate for Spyre Therapeutics (SYRE) over the last 5 years, with Q1 2025 value amounting to 0.03%.

  • Spyre Therapeutics' Tax Rate rose 1100.0% to 0.03% in Q1 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 300.0% down from last year.
  • As of Q1 2025, Spyre Therapeutics' Tax Rate stood at 0.03%, which was up 1100.0% from 0.0% recorded in Q4 2024.
  • In the past 5 years, Spyre Therapeutics' Tax Rate ranged from a high of 1.13% in Q3 2022 and a low of 1.37% during Q2 2021
  • For the 5-year period, Spyre Therapeutics' Tax Rate averaged around 0.05%, with its median value being 0.03% (2024).
  • In the last 5 years, Spyre Therapeutics' Tax Rate soared by 13300bps in 2022 and then tumbled by -11400bps in 2023.
  • Over the past 5 years, Spyre Therapeutics' Tax Rate (Quarter) stood at 0.11% in 2021, then crashed by -80bps to 0.2% in 2022, then soared by 96bps to 0.01% in 2023, then surged by 76bps to 0.0% in 2024, then surged by 1985bps to 0.03% in 2025.
  • Its Tax Rate stands at 0.03% for Q1 2025, versus 0.0% for Q4 2024 and 0.03% for Q3 2024.